Aspen Aerogels assumed at Hold from Buy at Benchmark
The Fly

Aspen Aerogels assumed at Hold from Buy at Benchmark

Benchmark analyst Subash Chandra downgraded Aspen Aerogels to Hold from Buy after assuming coverage of the stock. While the company has addressed key challenges with an equity raise, securing a loan from GM, and begining construction of a plant that "can multiply revenue capacity," revenue and margin translation has been inconsistent this year, Chandra said. The "pieces are in place to execute in 2023," added the analyst, who will reassess the firm’s rating based on performance.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on ASPN:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App